Estimate Recalculated Nov 11, 2024 07:54AM EST
Nina S Kjellson does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include TESARO, Inc., EnteroMedics Inc, Invuity, Inc., GLAUKOS Corp, Carbylan Therapeutics, Inc., Trius Therapeutics Inc, Tyra Biosciences, Inc., Panacea Acquisition Corp. II, Eiger BioPharmaceuticals, Inc., Marketo, Inc., Cidara Therapeutics, Inc., Transcept Pharmaceuticals Inc, and Ocera Therapeutics, Inc..
Nina S Kjellson's CIK is 0001381980
2016 was Nina S Kjellson's most active year for acquiring shares with 3 total transactions. Nina S Kjellson's most active month to acquire stocks was the month of May. 2013 was Nina S Kjellson's most active year for disposing of shares, totalling 5 transactions. Nina S Kjellson's most active month to dispose stocks was the month of August. 2016 saw Nina S Kjellson paying a total of $0.00 for 62,500 shares, this is the most they've acquired in one year. In 2013 Nina S Kjellson cashed out on 60,302 shares for a total of $483,807.42, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!